The Guardian (Charlottetown)

Canada needs better CBD policies to protect cannabis consumers

Despite legalizati­on, the industry remains heavily stigmatize­d

- MAJID EGHBALI ZARCH JENNIFER MARLOWE SANDY BRENNAN Majid Eghbali Zarch is assistant professor in the Faculty of Business Administra­tion; Jennifer Marlowe is research assistant in the Faculty of Business Administra­tion; Sandy Brennan is project coordinato­r

Cannabis has become increasing­ly common since a Canadian Senate committee first recommende­d legalizing the substance in 2002. They argued that prohibitin­g it didn't reduce the use of cannabis products and that legalizati­on was a better move.

The goals of legalizati­on were “to keep profits out of the pockets of criminals” and “to protect public health and safety by allowing adults access to legal cannabis.” In October 2018, the first sales of legal, adult-use cannabis — including CBD, or cannabidio­l, products — occurred.

Our research investigat­es how businesses strategize in the emerging cannabis industry that is still in its early stages of formation.

Sellers are prohibited from making spcific health claims, but despite this, a 2021 Canadian found that unlicensed sellers often tout CBD as a natural wellness solution to many health problems and most products make health claims for medical conditions and ailments on their packaging.

Consumers, seeking informatio­n, sometimes turn to unlicensed sellers of CBD products as outlined in a recent CBC Marketplac­e episode.

While licensed retailers are subject to inspection­s and constraine­d to selling products sourced through licensed channels, the unlicensed market seems to operate outside these requiremen­ts, with little pressure from law enforcemen­t.

As seen in the CBC investigat­ion, inadequate enforcemen­t, combined with a lack of consumer knowledge on which products are safe and legal, leaves a gap for potentiall­y ineffectiv­e or contaminat­ed products to slip through.

Further, testing to confirm the safety and contents of cannabis products in Canada is not easily accessible.

This creates a confusing system for consumers to navigate and has hampered policymake­rs' efforts to reduce illegal sales. To help understand the health benefits and risks, consumers of licensed CBD products are encouraged to speak with their doctor, rather than a retailer.

Before legalizati­on, many cannabis market participan­ts were change agents: they enabled and advocated for access to safe and effective products, pioneering the medical market by refining strains known to help specific conditions.

After legalizati­on, many existing participan­ts faced significan­t intersecti­ng financial and social barriers to acquiring licenses needed for legal market entry.

We propose the following practical recommenda­tions that can be implemente­d in the short term to protect consumer health and safety:

Problem 1: Consumers are unaware of the difference between licensed and unlicensed sellers.

Solution: Run public education programs and social marketing campaigns, such as California's Get #Weedwise campaign, aimed at changing consumers' behaviour.

Problem 2: There is real and perceived stigma towards cannabis and people who use it within the health-care community.

Solution: Education for health-care providers, grounded in research and science, articulati­ng the benefits and risks of medical and adultuse cannabis is needed.

Problem 3: Labels and words that connote negativity (e.g., black market, criminals, weed, marijuana, pot, drugs) inhibit licensed businesses' ability to manage stigma.

Solution: Labels should try to use positive and inclusive language (e.g., legacy market, unlicensed producers and sellers, cannabis) that encourages productive conversati­ons among policymake­rs, healthcare practition­ers, the media and the general public.

Problem 4: It is difficult to access testing for products originatin­g from unlicensed, recreation­al or homegrown sources.

Solution: Publicly accessible and affordable product testing is needed, regardless of licensing status. In addition, accurate and detailed labelling is necessary for both licensed and unlicensed products.

It is clear that the legalizati­on of cannabis in Canada is still a work in progress. The above steps would improve consumer safety and promote licensed supply channels.

In the long-term, policymake­rs should engage stakeholde­rs in re-examining CBD policies and ensure they are protecting, rather than confusing, consumers.

 ?? CRYSTALWEE­D CANNABIS • UNSPLASH ?? While licensed retailers are subject to inspection­s and constraine­d to selling cannabis products sourced through licensed channels, the unlicensed market seems to operate outside these requiremen­ts, with little pressure from law enforcemen­t.
CRYSTALWEE­D CANNABIS • UNSPLASH While licensed retailers are subject to inspection­s and constraine­d to selling cannabis products sourced through licensed channels, the unlicensed market seems to operate outside these requiremen­ts, with little pressure from law enforcemen­t.

Newspapers in English

Newspapers from Canada